EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Renal Outcomes and Variant Effects in Monoallelic COL4A3/COL4A4–Related Alport Syndrome

Diogo Fernandes da Rocha iD, Jorge Reis Almeida, Roberto Pestana Silva, Pedro Louro iD, Ana Paula Neto iD, Carla Pinto Moura iD, Susana Moreira Ferreira iD, João Paulo Oliveira iD

Kidney360 · 13.11.2026

DOI: 10.34067/kid.0000001455 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney360, online erschienen am 13.11.2026. Verfasst von Diogo Fernandes da Rocha und 7 weiteren Autor:innen. Beteiligte Einrichtung: Serviço de Genética Humana, Hospital Universitário de São João, Unidade Local de Saúde de São João, Porto, Portugal. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Autosomal dominant Alport syndrome (AD-AS) is caused by pathogenic/likely pathogenic (P/LP) variants in COL4A3 and COL4A4 . Its clinical spectrum ranges from isolated hematuria to proteinuric chronic kidney disease (CKD) eventually progressing to kidney failure (KF). We aimed to characterize the clinical and genetic profile of AD-AS in northwest Portugal, with particular focus on the recurrent COL4A3 c.1219G>C p.(Gly407Arg) variant.

Methods

We conducted an observational cohort study at a major university hospital. Eligible participants were heterozygous for COL4A3 or COL4A4 variants. Demographic, clinical, and genetic data were collected. Time to CKD≥3 and CKD5/KF was estimated using the Kaplan–Meier method. Subcohorts were defined by gene, variant type, and variant of interest.

Results

A total of 218 individuals (16 children) from 123 families were included. Definitive molecular diagnosis was obtained in 75%. Among COL4A3 carriers, 117 had P/LP variants, predominantly missense; among COL4A4 carriers, 47 had P/LP variants, predominantly truncating. COL4A3 p.(Gly407Arg) represented 62% of COL4A3 P/LP variants and 44% of the patient cohort. History of microscopic hematuria was present in 93% of patients, whereas history of significant proteinuria was documented in 68% and hypertension in 48%. CKD≥3 developed in 33%, and 21% progressed to CKD5/KF. Proteinuria independently predicted CKD progression (p=0.001). Carriers of COL4A3 p.(Gly407Arg) had earlier onset of hypertension and higher prevalence of proteinuria than carriers of other COL4A3 P/LP variants. Glomerular basement membrane thinning was noted on electron microscopy in all biopsy specimens. Extrarenal manifestations were uncommon.

Conclusions

Heterozygous COL4A3 / 4 P/LP variants are frequently associated with progressive CKD. COL4A3 p.(Gly407Arg) apparently confers a more penetrant renal phenotype. AD-AS demonstrates a continuum of phenotypes even among relatives, underscoring the importance of early identification, longitudinal monitoring, and renoprotective therapy.

Autor:innen und Institutionen

  • Serviço de Genética Humana, Hospital Universitário de São João, Unidade Local de Saúde de São João, Porto, Portugal.
  • Universidade Federal Fluminense, Hospital Universitário António Pedro, Laboratório Multiusuário de Apoio à Pesquisa em Nefrologia e Ciências Médicas, Niterói/Rio de Janeiro, Brasil.
  • Serviço de Anatomia Patológica, Hospital Universitário de São João, Unidade Local de Saúde de São João, Porto, Portugal.
  • Unidade de Patologia e Oncologia, Departamento de Patologia, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.
  • Faculdade de Ciências da Saúde, Universidade da Beira Interior, Covilhã, Portugal.
  • Serviço de Genética, Departamento de Patologia, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.

ORCID-Profile: Diogo Fernandes da Rocha, Pedro Louro, Ana Paula Neto, Carla Pinto Moura, Susana Moreira Ferreira, João Paulo Oliveira

Zitieren

APA

Fernandes da Rocha, D., Reis Almeida, J., Pestana Silva, R., Louro, P., Neto, A. P., Pinto Moura, C., Moreira Ferreira, S., & Paulo Oliveira, J. (2026). Renal Outcomes and Variant Effects in Monoallelic COL4A3/COL4A4–Related Alport Syndrome. Kidney360. https://doi.org/10.34067/kid.0000001455

Vancouver

Fernandes da Rocha D, Reis Almeida J, Pestana Silva R, Louro P, Neto AP, Pinto Moura C, et al. Renal Outcomes and Variant Effects in Monoallelic COL4A3/COL4A4–Related Alport Syndrome. Kidney360. 2026. doi:10.34067/kid.0000001455

BibTeX
@article{FernandesdaRocha2026,
  author = {Fernandes da Rocha, Diogo and Reis Almeida, Jorge and Pestana Silva, Roberto and Louro, Pedro and Neto, Ana Paula and Pinto Moura, Carla and Moreira Ferreira, Susana and Paulo Oliveira, João},
  title = {Renal Outcomes and Variant Effects in Monoallelic COL4A3/COL4A4–Related Alport Syndrome},
  journal = {Kidney360},
  year = {2026},
  doi = {10.34067/kid.0000001455}
}
Kostenlos starten →